HER Genetic Research Presented at ASHG

What is the cause of hyperemesis gravidarum? Dr. Fejzo presented our team’s results from the largest ever genetic study of HG (7,197 HG cases and 178,953 controls) at the American Society of Human Genetics annual conference in Los Angeles on October 26, 2022.

Read More

Dr. Fejzo is featured in Inverse

Dr. Marlena Fejzo, geneticist and HER’s Research Advisor and member of the Board of Directors, was featured in the Inverse article, “When morning sickness kills: doctors have dismissed hyperemesis gravidarum for decades, but new researc could undo this harmful legacy.”

Read More

HER Psychosocial Research

The HER Foundation’s breakthrough psychosocial study shows that Hyperemesis Gravidarum (HG) is not self limiting and has societal implications.

Read More

Best of 2021

We put together this list of highlights from 2021! These are some of the people, the work, and the campaigns that made this HER’s best year yet! We are making Hyperemesis Gravidarum (HG) progress!

Read More

HER Board Members Lead Study at USC

HER Board members, Marlena Fejzo, PhD, and Patrick Mullen, MD, are running the first study of GDF15 in HG patients in the United States.

Read More

Marlena Fejzo, PhD, presents on HER’s genetic research at ASHG Annual Meeting 2021

Marlena Fejzo, PhD, HER Board Member and Research Advisor, presents at the American Society of Human Genetics Annual Meeting on the genetics of Hyperemesis Gravidarum (HG).

Read More
mom and meds

Research Summary: Safety of Ondansetron (Zofran) in Pregnancy

Read the latest research on the safety of ondansetron (Zofran) in an HG pregnancy.

Read More

How to Support an Employee with HG or other High Risk Complications of Pregnancy

Dozens of mothers bravely raised their voices about the obstacles that prohibited them from being healthy, productive employees during their pregnancies, including insufficient job security and a lack of compassion from employers. We compiled their responses to make a succinct list employers can refer to when attempting to support employees with HG or other high risk pregnancy complications. 

Read More

Dr. Fejzo speaks at the Fetal Medicine Foundation

Dr. Marlena Fejzo, a geneticist at the University of Southern California and a HER Foundation Board of Directors, presented at the Fetal Medicine Foundation (FMF) about Hyperemesis Gravidarum (HG), its potential causes, and treatment options. Over 5600 medical professionals heard her speak, and the talk is freely available on the FMF’s website in English, Spanish, Russian, and Portuguese.

Read More

New Research Published: HELP Score

The HER Foundation publishes a new study demonstrating the effectiveness of the HyperEmesis Level Prediction (HELP) Score in identifying pregnant women with severe symptoms of NVP.

Read More